IL295754A - שיטות וריאגנטים לאבחון של זיהום sars-cov-2 - Google Patents
שיטות וריאגנטים לאבחון של זיהום sars-cov-2Info
- Publication number
- IL295754A IL295754A IL295754A IL29575422A IL295754A IL 295754 A IL295754 A IL 295754A IL 295754 A IL295754 A IL 295754A IL 29575422 A IL29575422 A IL 29575422A IL 295754 A IL295754 A IL 295754A
- Authority
- IL
- Israel
- Prior art keywords
- seq
- antibody
- sars
- antibodies
- iga
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20158348 | 2020-02-19 | ||
EP20158626.0A EP3715847A1 (en) | 2020-02-20 | 2020-02-20 | A method and reagents for the diagnosis of sars-cov-2 |
EP20158821 | 2020-02-21 | ||
DE202020104982 | 2020-08-28 | ||
PCT/EP2021/054113 WO2021165448A1 (en) | 2020-02-19 | 2021-02-19 | Methods and reagents for diagnosis of sars-cov-2 infection |
Publications (1)
Publication Number | Publication Date |
---|---|
IL295754A true IL295754A (he) | 2022-10-01 |
Family
ID=83598779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL295754A IL295754A (he) | 2020-02-19 | 2021-02-19 | שיטות וריאגנטים לאבחון של זיהום sars-cov-2 |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL295754A (he) |
-
2021
- 2021-02-19 IL IL295754A patent/IL295754A/he unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3809137A1 (en) | Methods and reagents for diagnosis of sars-cov-2 infection | |
KR102443389B1 (ko) | Sarsr-cov에 대한 항체의 검출 | |
EP3855186B1 (en) | A method for determining the efficacy of a sars-cov-2 vaccine | |
KR102262876B1 (ko) | 진단 분석에 사용하기 위한 단백질 항원으로서 rep 단백질 | |
JP7105970B1 (ja) | SARS-CoV-2の免疫測定方法及び免疫測定キット | |
JP7216948B1 (ja) | SARS-CoV-2の免疫測定方法及び免疫測定キット、並びにモノクローナル抗体又はその抗体断片 | |
Byrnes et al. | A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding | |
WO2005042579A1 (ja) | 抗sarsウイルス抗体、該抗体を産生するハイブリドーマ及び該抗体を用いる免疫測定試薬 | |
US20230221320A1 (en) | Serological assays for sars-cov-2 | |
US20130344474A1 (en) | Method and kit for detection of chronic hepatitis b | |
US9068993B2 (en) | Diagnostic assays and methods of use for detection of filarial infection | |
IL295754A (he) | שיטות וריאגנטים לאבחון של זיהום sars-cov-2 | |
EP3922262A1 (en) | Assay for the detection of the cys-like protease (mpro) of sars-cov-2 | |
WO2020241617A1 (ja) | 抗ヒトハプトグロビン抗体、及びこれを用いた炎症性腸疾患の判定方法 | |
US20240288440A1 (en) | Methods and compositions based on longitudinal studies | |
JP2003043044A (ja) | 抗体捕捉法による抗体の免疫学的測定方法 | |
WO2021240425A1 (en) | A method for rapid detection of antibodies against sars-cov-2 using recombinant nucleospike fusion protein | |
CN116635719A (zh) | 基于纵向研究的方法和组合物 | |
CN115280146A (zh) | 包含人iv型胶原7s结构域的片段的测定方法以及用于该测定方法的试剂盒 | |
JP2016191581A (ja) | トリパノソーマ感染症の検出方法 |